Narcolepsy Drugs Market Report by Type (Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, Secondary Narcolepsy), Disease Type (Daytime Extreme Sleepiness, Cataplexia, and Others), Therapeutic Type (Sodium Oxybate, Central Nervous System Stimulants, Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitor, and Others), and Region 2025-2033

Narcolepsy Drugs Market Report by Type (Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, Secondary Narcolepsy), Disease Type (Daytime Extreme Sleepiness, Cataplexia, and Others), Therapeutic Type (Sodium Oxybate, Central Nervous System Stimulants, Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitor, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A5685

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Narcolepsy Drugs Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Type
    6.1    Narcolepsy with Cataplexy
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Narcolepsy without Cataplexy
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Secondary Narcolepsy
        6.3.1 Market Trends
        6.3.2 Market Forecast
7   Market Breakup by Disease Type
    7.1    Daytime Extreme Sleepiness
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Cataplexia
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Others
        7.3.1 Market Trends
        7.3.2 Market Forecast
8   Market Breakup by Therapeutic Type
    8.1    Sodium Oxybate
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Central Nervous System Stimulants
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Tricyclic Antidepressants
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Selective Serotonin Reuptake Inhibitor
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Others
        8.5.1 Market Trends
        8.5.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Avadel Pharmaceuticals plc
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Axsome Therapeutics Inc.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
        14.3.3    Bioprojet Pharma
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
        14.3.4    Graymark Healthcare Inc.
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
        14.3.5    Jazz Pharmaceuticals plc
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    Ligand Pharmaceuticals Incorporated
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Novartis AG
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials
           14.3.7.4 SWOT Analysis
        14.3.8    SHIONOGI & Co. Ltd.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
           14.3.8.4 SWOT Analysis
        14.3.9    Takeda Pharmaceutical Company Limited
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis
        14.3.10    Teva Pharmaceutical Industries Ltd.
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis

List of Figures

Figure 1: Global: Narcolepsy Drugs Market: Major Drivers and Challenges
Figure 2: Global: Narcolepsy Drugs Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Narcolepsy Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Narcolepsy Drugs Market: Breakup by Type (in %), 2024
Figure 5: Global: Narcolepsy Drugs Market: Breakup by Disease Type (in %), 2024
Figure 6: Global: Narcolepsy Drugs Market: Breakup by Therapeutic Type (in %), 2024
Figure 7: Global: Narcolepsy Drugs Market: Breakup by Region (in %), 2024
Figure 8: Global: Narcolepsy Drugs (Narcolepsy with Cataplexy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Narcolepsy Drugs (Narcolepsy with Cataplexy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Narcolepsy Drugs (Narcolepsy without Cataplexy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Narcolepsy Drugs (Narcolepsy without Cataplexy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Narcolepsy Drugs (Secondary Narcolepsy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Narcolepsy Drugs (Secondary Narcolepsy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Narcolepsy Drugs (Daytime Extreme Sleepiness) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Narcolepsy Drugs (Daytime Extreme Sleepiness) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Narcolepsy Drugs (Cataplexia) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Narcolepsy Drugs (Cataplexia) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Narcolepsy Drugs (Other Disease Types) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Narcolepsy Drugs (Other Disease Types) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Narcolepsy Drugs (Sodium Oxybate) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Narcolepsy Drugs (Sodium Oxybate) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Narcolepsy Drugs (Central Nervous System Stimulants) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Narcolepsy Drugs (Central Nervous System Stimulants) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Narcolepsy Drugs (Tricyclic Antidepressants) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Narcolepsy Drugs (Tricyclic Antidepressants) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Narcolepsy Drugs (Selective Serotonin Reuptake Inhibitor) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Narcolepsy Drugs (Selective Serotonin Reuptake Inhibitor) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: Narcolepsy Drugs (Other Therapeutic Types) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: Narcolepsy Drugs (Other Therapeutic Types) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: North America: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: North America: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: United States: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: United States: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: Canada: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: Canada: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Asia-Pacific: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Asia-Pacific: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: China: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: China: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: Japan: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: Japan: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: India: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: India: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: South Korea: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: South Korea: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: Australia: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: Australia: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: Indonesia: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: Indonesia: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Others: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Others: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: Europe: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: Europe: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: Germany: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: Germany: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: France: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: France: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: United Kingdom: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: United Kingdom: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: Italy: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: Italy: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Spain: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Spain: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Russia: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Russia: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Others: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Others: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Latin America: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Latin America: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Brazil: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Brazil: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Mexico: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Mexico: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Others: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Others: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: Middle East and Africa: Narcolepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 77: Middle East and Africa: Narcolepsy Drugs Market: Breakup by Country (in %), 2024
Figure 78: Middle East and Africa: Narcolepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: Global: Narcolepsy Drugs Industry: SWOT Analysis
Figure 80: Global: Narcolepsy Drugs Industry: Value Chain Analysis
Figure 81: Global: Narcolepsy Drugs Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Narcolepsy Drugs Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Narcolepsy Drugs Market Forecast: Breakup by Type (in Million USD), 2025-2033
Table 3: Global: Narcolepsy Drugs Market Forecast: Breakup by Disease Type (in Million USD), 2025-2033
Table 4: Global: Narcolepsy Drugs Market Forecast: Breakup by Therapeutic Type (in Million USD), 2025-2033
Table 5: Global: Narcolepsy Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Narcolepsy Drugs Market: Competitive Structure
Table 7: Global: Narcolepsy Drugs Market: Key Players

Narcolepsy Drugs Market Report by Type (Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, Secondary Narcolepsy), Disease Type (Daytime Extreme Sleepiness, Cataplexia, and Others), Therapeutic Type (Sodium Oxybate, Central Nervous System Stimulants, Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitor, and Others), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials